Testing effectiveness (Phase 2)Study completedNCT04242264
What this trial is testing
Phase 2 Shigella Vaccine and Challenge
Who this might be right for
ImmunisationShigella Infection
National Institute of Allergy and Infectious Diseases (NIAID) 69
Showing 20 of 0 results